pamidronate has been researched along with Prosthesis Durability in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huk, OL | 1 |
Zukor, DJ | 1 |
Antoniou, J | 1 |
Petit, A | 1 |
Johansson, HR | 1 |
Skripitz, R | 1 |
Aspenberg, P | 1 |
Gburek, Z | 1 |
Rybicki, A | 1 |
Schwarz, EM | 1 |
Looney, RJ | 1 |
O'Keefe, RJ | 1 |
1 review available for pamidronate and Prosthesis Durability
Article | Year |
---|---|
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
Topics: Antibodies, Monoclonal; Cytochrome P-450 Enzyme System; Diphosphonates; Etanercept; Hip Prosthesis; | 2000 |
3 other studies available for pamidronate and Prosthesis Durability
Article | Year |
---|---|
Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Diphosphonates; Dose-Response Relationship, | 2003 |
Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Bone Screws; Diphosphonates; Drug A | 2008 |
[An attempt to treat loosening of the total hip endoprosthesis in Paget disease with Aredia].
Topics: Aged; Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Diphosphonates; Female; Humans; Oste | 1998 |